Syncom Formulations (India) Limited (SYNCOMF) - Cash Flow Conversion Efficiency

Latest as of September 2023: 0.007x

Based on the latest financial reports, Syncom Formulations (India) Limited (SYNCOMF) has a cash flow conversion efficiency ratio of 0.007x as of September 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs17.58 Million ≈ $190.08K USD) by net assets (Rs2.70 Billion ≈ $29.22 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Syncom Formulations (India) Limited balance sheet independence to measure how much of total assets are equity-financed.

Syncom Formulations (India) Limited - Cash Flow Conversion Efficiency Trend (2006–2025)

This chart illustrates how Syncom Formulations (India) Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check SYNCOMF cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.

Syncom Formulations (India) Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Syncom Formulations (India) Limited ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Mpact Limited
JSE:MPT
-0.008x
Bank Capital Indonesia Tbk
JK:BACA
-0.276x
Choppies Enterprises Ltd
JSE:CHP
0.910x
Ya Horng Electronic Co Ltd
TW:6201
0.023x
RF Acquisition Corp III Ordinary Shares
NASDAQ:RFAM
-0.001x
PRECIA SA EO -50
F:P1E0
N/A
Smec Co.Ltd
KQ:099440
-0.027x
Ceres Global Ag Corp
TO:CRP
0.066x

Annual Cash Flow Conversion Efficiency for Syncom Formulations (India) Limited (2006–2025)

The table below shows the annual cash flow conversion efficiency of Syncom Formulations (India) Limited from 2006 to 2025. For the full company profile with market capitalisation and key ratios, see SYNCOMF market cap overview.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-03-31 Rs3.42 Billion
≈ $37.00 Million
Rs234.36 Million
≈ $2.53 Million
0.068x +430.29%
2024-03-31 Rs2.87 Billion
≈ $31.07 Million
Rs-59.58 Million
≈ $-644.37K
-0.021x -150.42%
2023-03-31 Rs2.56 Billion
≈ $27.69 Million
Rs105.29 Million
≈ $1.14 Million
0.041x -44.03%
2022-03-31 Rs2.22 Billion
≈ $24.03 Million
Rs163.29 Million
≈ $1.77 Million
0.073x +791.44%
2021-03-31 Rs1.88 Billion
≈ $20.29 Million
Rs-19.93 Million
≈ $-215.59K
-0.011x -206.10%
2020-03-31 Rs1.46 Billion
≈ $15.75 Million
Rs-5.06 Million
≈ $-54.69K
-0.003x -110.64%
2019-03-31 Rs1.33 Billion
≈ $14.34 Million
Rs43.29 Million
≈ $468.17K
0.033x +348.68%
2018-03-31 Rs1.22 Billion
≈ $13.19 Million
Rs-16.01 Million
≈ $-173.10K
-0.013x -111.13%
2017-03-31 Rs1.17 Billion
≈ $12.69 Million
Rs138.41 Million
≈ $1.50 Million
0.118x -46.97%
2016-03-31 Rs1.09 Billion
≈ $11.76 Million
Rs241.74 Million
≈ $2.61 Million
0.222x +11832.06%
2015-03-31 Rs1.00 Billion
≈ $10.84 Million
Rs1.87 Million
≈ $20.20K
0.002x -97.36%
2014-03-31 Rs951.99 Million
≈ $10.30 Million
Rs67.30 Million
≈ $727.87K
0.071x +7.30%
2013-03-31 Rs877.09 Million
≈ $9.49 Million
Rs57.79 Million
≈ $624.96K
0.066x -14.20%
2012-03-31 Rs836.08 Million
≈ $9.04 Million
Rs64.20 Million
≈ $694.33K
0.077x +281.55%
2011-03-31 Rs816.58 Million
≈ $8.83 Million
Rs-34.54 Million
≈ $-373.52K
-0.042x -381.24%
2010-03-31 Rs550.47 Million
≈ $5.95 Million
Rs-4.84 Million
≈ $-52.32K
-0.009x +51.59%
2009-03-31 Rs411.32 Million
≈ $4.45 Million
Rs-7.47 Million
≈ $-80.76K
-0.018x -112.90%
2008-03-31 Rs390.34 Million
≈ $4.22 Million
Rs54.94 Million
≈ $594.11K
0.141x -0.43%
2007-03-31 Rs342.37 Million
≈ $3.70 Million
Rs48.40 Million
≈ $523.37K
0.141x +69.71%
2006-03-31 Rs292.59 Million
≈ $3.16 Million
Rs24.37 Million
≈ $263.55K
0.083x --

About Syncom Formulations (India) Limited

NSE:SYNCOMF India Drug Manufacturers - Specialty & Generic
Market Cap
$137.95 Million
Rs12.76 Billion INR
Market Cap Rank
#17946 Global
#963 in India
Share Price
Rs13.57
Change (1 day)
+0.00%
52-Week Range
Rs10.30 - Rs18.36
All Time High
Rs26.77
About

Syncom Formulations (India) Limited manufactures, markets, and sells pharmaceutical formulation products in India and internationally. It operates through Manufacturing and Dealing in Pharmaceutical Drug and Formulations, Trading of Commodities, and Renting of Properties segments. The company offers antibiotics/antiinfectives, anthelmintics, antimalarial, cardiac, derma, gastro, dry syrups and su… Read more